Literature DB >> 7430889

Release, distribution and half-life of alpha-melanotrophin in the rat.

J F Wilson, F M Harry.   

Abstract

Concentrations of alpha-melanotrophin in the plasma of anaesthetized rats were measured by radioimmunoassay at intervals of 2-10 min. Although significant increases of three to ten times in the concentration of alpha-melanotrophin occurred over periods of 15-35 min, levels of hormone could also be stable for periods of greater than 1 h. The data did not indicate separate secretory episodes but rather a continuous release of alpha-melanotrophin by the pituitary gland. A very rapid pulsatile secretion operating over periods of less than 5 min cannot be excluded. Intravenous injection of synthetic alpha-melanotrophin was followed by a biexponential decline in levels of hormone in plasma indicating a rapid distribution to the extracellular fluid and a slower elimination by metabolism. The apparent volume of distribution of alpha-melanotrophin was 210 ml/kg, the half-life for elimination 7.1 min and the estimated clearance 1.55 nmol/day per kg.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430889     DOI: 10.1677/joe.0.0860061

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  2 in total

1.  Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice.

Authors:  Eva-Verena Schaible; Arne Steinsträßer; Antje Jahn-Eimermacher; Clara Luh; Anne Sebastiani; Frida Kornes; Dana Pieter; Michael K Schäfer; Kristin Engelhard; Serge C Thal
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

2.  α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes.

Authors:  Lijuan Zhang; Lijie Dong; Xun Liu; Yuanfeng Jiang; Lingjun Zhang; Xiaomin Zhang; Xiaorong Li; Yan Zhang
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.